TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/23 18:22 | 5/12/23 | BNGO | Bionano Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Stewart Christopher P. | CA | O | CFO | P | 33 | 0.6683 | 0 | 50 | 22 | 281 | D | ||||||||||||||
5/16/22 21:31 | 5/13/22 | BNGO | Bionano Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Stewart Christopher P. | CA | O | CFO | M.d | 34 | 0.5600 | 0 | 60 | 97 | 122 | D | ||||||||||||||
11/23/21 06:00 | 11/19/21 | BNGO | Bionano Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Stewart Christopher P. | CA | O | CFO | M.d | 13 | 0.5600 | 0 | 23 | 68 | 56 | D | ||||||||||||||
5/27/21 16:36 | 5/26/21 | BNGO | Bionano Genomics, Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Stewart Christopher P. | CA | O | CFO | M.d | 14 | 0.5600 | 0 | 25 | 313 | 33 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |